Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Stock-based Compensation (Tables)

v3.24.1.1.u2
Note 13 - Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Notes Tables  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
   

Awards Reserved for Issuance

   

Awards Exercised

   

Awards Outstanding

   

Awards Available for Grant

 

2016 Equity Incentive Plan

    2,000,000             2,489       1,997,511  

2018 Equity Incentive Plan

    43,976,425       40,221       245,871       43,690,333  

2019 Equity Incentive Plan

    55,000,000       349       119,992       54,879,659  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
   

(in thousands, except for shares / options)

 
   

For the Three Months Ended

 
   

March 31, 2024

   

March 31, 2023

 
   

Number of

           

Number of

         
   

Shares or

   

Stock-Based

   

Shares or

   

Stock-Based

 
   

Options

   

Compensation

   

Options

   

Compensation

 

Type of Award

 

Granted

   

Expense

   

Granted

   

Expense

 

Stock Options

        $ 110           $ 99  
                                 

Stock Grants:

                               

Employees (Common Stock)

                       

Directors (Common Stock)

                       

Non–Employee Consultants (Common Stock)

                161,812       356  

Total StockBased Compensation Expense

          $ 110             $ 455  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
                   

Weighted-

   

Aggregate

 
                   

Average

   

Intrinsic

 
           

Weighted-

   

Remaining

   

Value of

 
   

Number of

   

Average Exercise

   

Contractual

   

In-the-Money

 
   

Shares

   

Price Per Share

   

Life (in years)

   

Options

 

Options Outstanding as of January 1, 2024

    369,301     $ 13.00                  

Options Outstanding as of March 31, 2024

    369,301     $ 12.58       8.0 years     $  

Options Exercisable as of March 31, 2024

    360,333     $ 12.57       8.1 years     $